Tag: moderna

Moderna Scientists Warn mRNA Vaccines Carry Toxicity Risks

The technology used in Moderna’s COVID-19 vaccine carries toxicity risks, scientists with the company said in a new paper.

“A major challenge now is how to efficiently de-risk potential toxicities associated with mRNA technology,” the scientists wrote in the paper, which was published by Nature Reviews Drug Discovery on Jan. 23.

The Moderna and Pfizer COVID-19 shots use modified messenger ribonucleic acid (mRNA) technology. The mRNA is delivered by lipid nanoparticles (LNP).

The toxicity risks include “lipid nanoparticle structural components, production methods, route of administration and proteins produced from complexed mRNAs,” the authors of the paper said.

Authors of the paper include Eric Jacquinet and Dimitrios Bitounis, Moderna employees, and Maximillian Rogers, who was working at Moderna when the paper was being done.

Moderna didn’t respond to a request for comment.

The mRNA vaccines have multiple known side effects, including heart inflammation and severe allergic shock. Those may stem from hypersensitivity reactions, which can be elicited by “any LNP-mRNA component” but are most likely triggered by PEGlyated lipid nanoparticles, which is “the most potentially reactogenic component,” the scientists said.

Polyethylene glycol, or PEG, an ingredient in the Pfizer and Moderna COVID-19 vaccines, is known to cause allergic reactions. Outside scientists are divided over the mechanism behind the heart inflammation, while Pfizer has posited that the LNPs are behind the issue.

The new paper drew from prior publications and other data. The authors didn’t carry out any new experiments.

Keep reading

New Documents Provide More Insights on Moderna’s Online Speech Monitoring Efforts

Controversies originating from those who gained the most from the pandemic – most visibly, Big Pharma – refuses to go away.

One of the leading (and among the earliest) producers of Covid vaccines was US-based Moderna. We know for sure that the vaccine worked for Moderna – turning it from the verge of collapse into a $100 billion company, Defender reports.

But in large part due to the unusual speed with which vaccines were put through trials and then to market, many people – from regular citizens to public figures to medical professionals and scientists – felt skepticism about their efficacy and safety.

Expressing that openly, though, tended to get those people canceled or at least monitored and/or censored, and now new documents reveal Moderna’s role. Among them were journalists Alex Berenson, Stanford Health Policy professor Jay Bhattacharya, and actor Russell Brand.

In one instance, they “flagged a Russell Brand video in which he raised concerns about former British health official Jonathan Van-Tam, who was instrumental in COVID-19 policymaking and then took a high-level job at Moderna,” writes Defender.

Despite the billions in revenues raked in by Big Pharma, this obviously wasn’t enough, especially once the Covid panic started to subside and vaccine sales stalled.

And so Moderna sought out online media surveillance partners, and found one in the Public Goods Projects non-profit (otherwise receiving funds from Big Pharma), which was then useful in getting Covid vaccine skeptics silenced or censored on Twitter – Moderna and its partner, of course, called this combating “medical information.”

Keep reading

Moderna Engaged in Covert Operations to Control Online Criticism of Vaccines

Moderna, known for its mRNA coronavirus vaccine, reportedly engaged in extensive surveillance and influence operations, attempting to remove criticism or pushback against its vaccine from online discourse.

UnHerd reports that Moderna, the biotech firm raised to prominence by its mRNA coronavirus vaccine, is now at the center of a complex and controversial situation. While it achieved a staggering $100 billion valuation during the pandemic, recent reports suggest the company ventured beyond pharmaceutical innovation into the world of surveillance and public influence.

According to the report from UnHerd, Moderna developed an intricate network of monitoring that it aimed to use to influence the public discourse on vaccines. Central to this operation is a collaboration with Public Good Projects (PGP), a drug industry-funded NGO, and former law enforcement officials, aimed at combating what the company considers to be vaccine misinformation. However, this initiative’s scope and methods have sparked significant concerns about the blurring lines between public health advocacy and corporate surveillance.

During the  pandemic, Moderna transformed almost overnight from a fledgling biotech firm to a household name, thanks to the widespread use of its mRNA vaccine. However, as the demand for vaccinations waned, so did Moderna’s earnings. In response, Moderna not only increased vaccine prices but also embarked on a marketing campaign to maintain its relevance in the public health sphere.

The company’s surveillance arm, led by Nikki Rutman, a former FBI analyst, monitors a vast array of mainstream and alternative media outlets. Utilizing advanced technology like Talkwalker’s “BlueSilk” AI, the team tracks vaccine-related conversations across millions of websites globally. High-risk alerts are raised for narratives that could potentially harm Moderna’s interests or bolster anti-vaccine sentiments.

This proactive approach to monitoring and influencing vaccine discourse extends to scrutinizing public figures like Elon Musk and Russell Brand. Moderna’s reporting on public figures’ comments on vaccines does not necessarily dispute their claims but flags them as misinformation if they are perceived to encourage vaccine hesitancy.

Keep reading

Top FDA Officials Accepted Jobs With Moderna After Playing Key Roles In The Licensure Of COVID-19 Vaccines

A new BMJ investigation reveals a “revolving door” between FDA officials tasked with regulating COVID-19 vaccines and the companies who manufacture them.

Two high-level regulatory officials with the U.S. Food and Drug Administration (FDA) involved in vaccine oversight accepted jobs at Moderna just months after signing off on the licensure of the company’s COVID-19 vaccine, according to a British Medical Journal (BMJ) investigation.

The report by Peter Doshi, associate professor at the University of Maryland School of Pharmacy and senior editor at The BMJ, reveals a long-standing revolving door between the FDA and pharmaceutical companies whose products it regulates and raises questions about the impartiality and independence of top FDA regulators.

Dr. Doran Fink is a “physician/scientist experienced in regulation and clinical development/licensure of vaccines and related biological products” and was deeply involved with vaccine regulation at the FDA for more than 12 years, according to his LinkedIn profile.

According to the BMJ report, Dr. Fink started his FDA career as a clinical reviewer in 2010 and “worked his way up” to Deputy Director of the Division of Vaccines and Related Product Applications within the FDA’s Office of Vaccines Research and Review, where he led a team of medical officers focused on infectious diseases and related biological projects.

During the COVID-19 pandemic, Dr. Fink was a prominent voice on COVID-19 vaccines and which population groups should receive them. He spoke on behalf of the FDA at numerous meetings held by the agency’s vaccine advisors who met to discuss whether to approve COVID-19 vaccines, change their composition, or authorize boosters.

Dr. Fink also presented at meetings held by the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices—a group of health experts that develop recommendations on how to use vaccines—as the FDA’s “principal FDA ex officio representative.”

According to the BMJ report and Dr. Fink’s LinkedIn profile, Fink also served on the senior leadership team for COVID-19 vaccine review and policy activities in response to the COVID-19 public health emergency.

As part of his role, he advised vaccine manufacturers on vaccine development throughout the pandemic and coordinated “expedited review of regulatory submissions,” advised U.S. government stakeholders outside the FDA on COVID-19 vaccine science and development, and contributed to FDA guidance on the development, licensure, and emergency use authorization of COVID-19 vaccines.

Keep reading

Subclinical Heart Damage More Prevalent Than Thought After Moderna Vaccination

Damage to the heart is more common than thought after receipt of Moderna’s COVID-19 booster, a new study indicates.

One in 35 health care workers at a Swiss hospital had signs of heart injury associated with the vaccine, mRNA-1273, researchers found.

“mRNA-1273 booster vaccination-associated elevation of markers of myocardial injury occurred in about one out of 35 persons (2.8%), a greater incidence than estimated in meta-analyses of hospitalized cases with myocarditis (estimated incidence 0.0035%) after the second vaccination,” the researchers wrote in the paper, published by the European Journal of Heart Failure.

In a generally healthy population, the level would be about 1 percent, the researchers said.

The group experiencing the adverse effects was followed for only 30 days, and half still had unusually high levels of high-sensitivity cardiac troponin T, an indicator of subclinical heart damage, at follow-up.

The long-term implications of the study remain unclear as little research has tracked people over time with heart injury after messenger RNA vaccination, which is known to cause myocarditis and other forms of heart damage.

“According to current knowledge, the cardiac muscle can’t regenerate, or only to a very limited degree at best. So it’s possible that repeated booster vaccinations every year could cause moderate damage to the heart muscle cells,” University Hospital Basel professor Christian Muller, a cardiologist and the lead researcher, said in a statement.

Moderna did not respond to a request for comment.

None of the patients experienced a major adverse cardiac event, such as heart failure, within 30 days of booster vaccination, and none had electrocardiogram changes.

The people with elevated levels were advised to avoid strenuous exercise, which may have mitigated more serious problems, the researchers said.

No imaging was done to examine the participants’ hearts, despite imaging being recommended by many cardiologists in cases of suspected vaccine-induced myocarditis.

It’s possible that imaging would have revealed inflammation, which could cause scarring or irregular heartbeat, Dr. Andrew Bostom, a heart expert in the United States who was not involved in the research, told The Epoch Times.

Dr. Anish Koka, an American cardiologist, said that the findings were “super useful to see how ‘cardioactive’ the booster is” but that it was hard to say how significant the elevated troponin levels were, particularly without a comparison to baseline levels. “There is really nothing clinically concerning at 30 days to report,” he said on Twitter.

Keep reading

The Biden Administration’s Strange, Secret Effort to Bail Out Moderna

American taxpayers have already given Moderna $10 billion for its coronavirus vaccine. If the Biden administration gets its wish, that tab could soon grow.

In a court filing last month, Department of Justice lawyers offered to “relieve” Moderna of any liability it faces from a lawsuit that accuses the drug company of failing to pay licensing fees for technology it used to develop its vaccine during “Operation Warp Speed.” Moderna has argued that the federal government should be on the hook for any legal settlement because of a stipulation in its contract that protects the company from patent litigation. The government had stayed silent on the matter until last month, when Justice Department lawyers said that any liability that Moderna faces should “transfer” to the United States government, citing a World War I-era law that protects federal contractors from patent disputes.

While the judge handling the case recently denied the request, Moderna and the federal government could appeal the decision and put taxpayers on the hook for any legal payout. Genevant, one of the companies that sued Moderna, has already accused the drug maker of “trying to shift responsibility for its patent infringement to the U.S. taxpayer.”

Keep reading

Are Fauci, Gates & Moderna responsible for the COVID Pandemic? – The U.S. D.O.D issued a ‘COVID-19 Research’ contract 3 Months before COVID was known to exist – & Fauci & Moderna had a Vaccine ready in Dec. 2019

The discovery of a contract awarded by the U.S. Department of Defense to Labyrinth Global Health for “COVID-19 Research” in November 2019 has raised questions about the permanent U.S. Government’s knowledge of the novel coronavirus.

The contract was part of a larger project for a “Biological threat reduction program in Ukraine,” suggesting the permanent U.S. Government was at the very least aware of the alleged virus before it spread through Wuhan, China in December 2019.

But the findings also suggest the permanent U.S. Government may have had a hand in the creation of this alleged virus in Biolabs through Gain of Function Research overseen by Dr Anthony Fauci.

This would explain why they knew the name of the novel coronavirus disease three months prior to the World Health Organization officially naming it Covid-19 in February 2020.

And it may also explain why Moderna and Fauci’s National Institute of Allergy and Infectious Diseases (NIAID) had a confidentiality agreement for an mRNA Coronavirus vaccine candidate in early December 2019, which was developed and jointly owned by Moderna and Fauci’s NIAID.

Keep reading

Campaign funded by Pfizer and Moderna lobbyists sent Twitter weekly lists of tweets to censor

The Public Good Projects (PGP), a nonprofit that has developed several projects to fight so-called Covid “misinformation,” received $1,275,000 from the Pfizer and Moderna lobbying group, Biotechnology Innovation Organization (BIO), to create a content moderation campaign that influenced Twitter’s Covid misinformation rules. As part of this campaign, PGP sent Twitter lobbyists and content moderators weekly emails containing lists of tweets to censor.

Journalist Lee Fang published one of the weekly emails that Twitter received from PGP as part of the latest release of the Twitter Files — collections of internal Twitter communications that have exposed the censorship relationships Twitter had with government agencies and other powerful groups before Elon Musk took over.

The email shows Todd O’Boyle, a senior manager on Twitter’s Public Policy team, sharing “this week’s misinfo report” from PGP. The February 24, 2022 email included a list of top trends the PGP had seen during the week and two attached lists. According to Fang, one of the lists contained tweets the PGP wanted Twitter to take down and the other list contained tweets that it wanted Twitter to verify.

Keep reading

Here We GO: Moderna CEO Announces New mRNA Shot for Heart Failure Patients to Help “Grow Back New Blood Vessels”

Stéphane Bancel, CEO of Moderna, announced the development of a new mRNA shot to treat patients suffering from heart failure.

In a statement released on Monday, the pharmaceutical company said it currently has 48 programs in development, including 36 programs that are currently being tested in clinical trials.

These programs include mRNA infectious disease vaccines and mRNA therapeutics that span seven different modalities.

“We enter 2023 in a great position, with significant momentum across our clinical pipeline, a highly energized team and a strong balance sheet of over $18 billion of cash and cash equivalents,” said Stéphane Bancel, Chief Executive Officer of Moderna.

Keep reading

FDA vaccine advisers ‘disappointed’ and ‘angry’ that early data about new Covid-19 booster shot wasn’t presented for review last year


Some vaccine advisers to the federal government say they’re “disappointed” and “angry” that government scientists and the pharmaceutical company Moderna didn’t present a set of infection data on the company’s new Covid-19 booster during meetings last year when the advisers discussed whether the shot should be authorized and made available to the public.

That data suggested the possibility that the updated booster might not be any more effective at preventing Covid-19 infections than the original shots.

The data was early and had many limitations, but several advisers told CNN that they were concerned about a lack of transparency.

US taxpayers spent nearly $5 billion on the new booster, which has been given to more than 48.2 million people in the US.

Keep reading